The countersuit, filed Aug. 5 in the Western District of Missouri, comes after BCBS of Kansas City filed a lawsuit against GS Labs July 21 alleging it had filed $9.2 million in inflated claims related to COVID-19 testing.
The payer claimed GS Labs had charged $380 for tests that were a wholesale price of $20.
GS Labs said in its countersuit that it had published the $380 fee for its rapid antigen tests online in accordance with the CARES Act.
“Blue KC’s reference to alleged wholesale prices demonstrates its underlying contempt for the valuable services that GS Labs provided,” court documents obtained by KSHB said.
GS Labs also said Blue KC violated the CARES Act by refusing to pay for COVID-19 testing.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
